The deal tape
A precedent transactions set answers one question: what did somebody actually pay for a company like this one. Every row here is a US public target that filed a merger proxy or a going-private statement since 2020, with the offer per share, the premium to the unaffected price and the enterprise value multiples read from the filing itself rather than bought from a feed. Choose a sector, an industry code and a size band, and the quartiles above the list are the answer for that cut.
What it is not. Private-company deals, non-US targets and any transaction where no proxy was required leave nothing to read, so none of them are here. Neither are minority stakes or asset sales. Where a cross-check failed, the row still appears and says why, and it is held out of every median and quartile so one bad reading cannot move a number you would quote.
3,168 deals with an offer price on the filing, 1,718 of them safe to take a multiple from and 3,113 safe to take a premium from. Enterprise value is stated where a balance sheet and a share count could be read at the period end before announcement.
What this cut was bought at
Each measure counts the readings that survive its own cross-checks. Fewer than 4 is a coincidence, not a market.
| Measure | Deals | 25th | Median | 75th |
|---|---|---|---|---|
| EV / LTM EBITDA | 875 | 8.1x | 12.7x | 19.5x |
| EV / LTM revenue | 1289 | 0.7x | 1.6x | 3.5x |
| Premium to unaffected price | 1548 | 18% | 31% | 50% |
| Premium to 30-day VWAP | 278 | 15% | 30% | 48% |
Read the EBITDA multiple against the revenue multiple before you use either. Where they disagree sharply the target was priced on growth rather than earnings, and the EBITDA line is the one that will not survive a second question.
| Target | Acquirer | Industry | EV | EV / EBITDA | EV / revenue | Premium | Filing |
|---|---|---|---|---|---|---|---|
ReNew Energy Global plc 2026-09-22 (filed) · Take-private · $7.02 a share Held out of the multiples: no balance sheet at announcement: EV = equity value Board book on file → | C/o Renew Private LTD Strategic | Utilities | $1.7bn | n.a. | n.a. | 13% | SC 13E3 All cash |
Luxfer Holdings plc 2026-09-17 (filed) · Public merger · $17.37 a share | Not named in the filing Unclassified | Healthcare | $512m | 16.5x | 1.4x | 31% | DEFM14A All cash |
Herzfeld Credit Income Fund, Inc 2026-09-17 (filed) · Take-private · $2.59 a share Held out of the multiples: no balance sheet at announcement: EV = equity value | Not named in the filing Unclassified | Other | $5m | n.a. | n.a. | n.a. | SC 13E3 All cash |
Gran Tierra Energy Inc. 2026-09-15 (filed) · Public merger · $9.73 a share | Not named in the filing Unclassified | Energy | $815m | n.a. | 1.3x | n.a. | DEFM14A All cash |
Weave Communications, Inc. 2026-08-18 · Public merger · $7.40 a share | Willow Parent, LLC Unclassified | Technology | $544m | n.a. | 2.1x | 34% | DEFM14A All cash |
Bowman Consulting Group Ltd. 2026-08-10 · Public merger · $43.00 a share | Prive Parent, Inc. Unclassified | Business Services | $780m | 21.1x | 1.5x | 58% | DEFM14A All cash |
Varex Imaging Corp 2026-08-10 · Public merger · $18.90 a share | Teledyne Technologies Incorporated Strategic | Technology | $1.0bn | 11.0x | 1.2x | n.a. | DEFM14A All cash |
Marinemax Inc 2026-08-09 · Public merger · $53.00 a share | SHM Holdco, LLC Unclassified | Consumer & Retail | $1.4bn | 11.6x | 0.6x | 96% | DEFM14A All cash |
Cherry Hill Mortgage Investment Corp 2026-08-09 · Public merger · $0.41 a share Held out of the multiples: consideration includes stock: the cash figure is not the price | AG REIT Management, LLC Financial sponsor | Real Estate | $105m | n.a. | n.a. | 29% | DEFM14A Includes stock |
Beazer Homes Usa Inc 2026-08-06 · Public merger · $33.50 a share | Dream Finders Homes, Inc. Strategic | Other | $766m | n.a. | 0.4x | 8% | DEFM14A All cash |
Sunrise Realty Trust, Inc. 2026-08-05 · Public merger · $0.05 a share Held out of the multiples: consideration includes stock: the cash figure is not the price | Southern Realty Trust Inc. Strategic | Real Estate | -$5m | n.a. | -0.2x | n.a. | DEFM14A Includes stock |
Lantheus Holdings, Inc. 2026-08-03 · Public merger · $102.50 a share | Curium US Holdings LLC Strategic | Healthcare | $6.7bn | 17.1x | 4.3x | n.a. | DEFM14A All cash |
Integer Holdings Corp 2026-08-02 · Public merger · $127.00 a share Held out of the multiples: consideration includes stock: the cash figure is not the price | Armstrong Parent, Inc. Unclassified | Healthcare | $5.5bn | 17.5x | 3.0x | 52% | DEFM14A Includes stock |
Atkore Inc. 2026-08-02 · Public merger · $95.00 a share | Prysmian S.p.A. Strategic | Technology | $3.6bn | 21.7x | 1.2x | 30% | DEFM14A All cash |
Bowhead Specialty Holdings Inc. 2026-08-02 · Take-private · $34.00 a share Board book on file → | Not named in the filing Strategic | Financials | $1.1bn | n.a. | 1.8x | 11% | SC 13E3 All cash |
LogicMark, Inc. 2026-07-31 · Take-private · $1.31 a share Held out of the premiums: premium of 256%: distressed or misread | Langham Project, LLC Controlling holder | Healthcare | -$5m | n.a. | -0.4x | 256% | SC 13E3 All cash |
Zoned Properties, Inc. 2026-07-30 (filed) · Public merger · $0.38 a share | Not named in the filing Unclassified | Real Estate | $9m | n.a. | 2.0x | n.a. | DEFM14A All cash |
Sanara MedTech Inc. 2026-07-29 · Public merger · $33.00 a share Held out of the multiples: consideration includes stock: the cash figure is not the price | MiMedx Group, Inc. Strategic | Healthcare | $334m | 19.9x | 3.0x | 35% | DEFM14A Includes stock |
Marketaxess Holdings Inc 2026-07-29 · Public merger · $167.00 a share Held out of the multiples: consideration includes stock: the cash figure is not the price | Intercontinental Exchange, Inc. Strategic | Financials | $5.8bn | 13.5x | 6.7x | 33% | DEFM14A Includes stock |
CBIZ, Inc. 2026-07-28 · Public merger · $55.00 a share | Viking ParentCo, Inc. Strategic | Business Services | $4.4bn | 15.4x | 1.6x | 62% 54% to VWAP | DEFM14A All cash |
Safety Insurance Group Inc 2026-07-23 · Public merger · $105.00 a share | MAPFRE U.S.A. Corp. Strategic | Financials | $1.5bn | n.a. | 1.2x | 45% | DEFM14A All cash |
Biolife Solutions Inc 2026-07-21 · Public merger · $11.25 a share Held out of the multiples: consideration includes stock: the cash figure is not the price; EV / LTM EBITDA 99.4x outside 1x to 75x | Repligen Corporation Strategic | Healthcare | $467m | 99.4x | 4.5x | 15% | DEFM14A Includes stock |
Personalis, Inc. 2026-07-20 · Take-private · $16.25 a share Board book on file → | Aviary Development, Inc Strategic | Healthcare | $1.5bn | n.a. | 21.4x | n.a. | SC 13E3 All cash |
Utz Brands, Inc. 2026-07-20 · Take-private · $14.25 a share Held out of the multiples: consideration includes stock: the cash figure is not the price | Idaho USA, Inc. Strategic | Consumer & Retail | $2.0bn | 21.0x | 1.4x | 91% 92% to VWAP | SC 13E3 Includes stock |
LXP Industrial Trust 2026-07-19 · Public merger · $61.20 a share Held out of the multiples: EV / LTM revenue 1208.1x above 60x | Leopard REIT LLC Strategic | Real Estate | $5.0bn | n.a. | 1208.1x | 5% 12% to VWAP | DEFM14A All cash |
How to use a set like this
Cut to the narrowest set that still holds eight or ten deals, then quote the range rather than the median. An interviewer who asks where software takes out will accept a spread and press on a single number, because the single number implies a precision the set does not have. Say which deals sit at each end and why: the top of a range is usually a contested auction or a strategic buyer with synergies, the bottom a controlling holder buying in the minority.
Premiums move with the reference price, not only with the deal. A bidder quotes the period that flatters the offer, so read the premium to the unaffected close beside the premium to the thirty-day average and notice when they diverge.
What each column means
- Enterprise value.
- Offer per share times shares outstanding, plus net debt at the last balance sheet before the merger agreement. It is blank where either piece was missing, and those rows are in the “not computed” band rather than in a size they never earned.
- Premium.
- The offer against the unaffected price, which is the last close before the deal became known. Where the filing states a premium to the thirty-day volume-weighted average, that is shown next to it.
- Deal type.
- A take-private is bought by an affiliate, which is what triggers the Schedule 13E-3 and the fuller disclosure that comes with it. A public merger is an arm’s-length buyer, disclosed through the merger proxy.
- In doubt.
- A cross-check the reading could not satisfy: an equity value far from the fee-table figure, a multiple outside any sane band, or consideration that is partly stock so the per-share cash figure is not the price. The row stays visible, and it is set aside only for the measures the doubt reaches. A cash-and-stock deal cannot price a multiple and still states a premium the filing itself computed, so it counts in one and not the other.
Company names, tickers and logos are the trademarks of their respective owners and appear here to identify the company whose public figures are being used. L3VLUP is not affiliated with, sponsored by or endorsed by any company shown, and nothing here is a statement by or about that company. More
The tape, weekly
One email a week on the deals that printed, the ones that broke, and what each says about the market you are about to be asked about.
One email a week, free, and you can leave at any point.